Skip to main content
SpringerLink
Log in

Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Excessive proliferation of vascular smooth muscle cells (VSMCs) is a critical element in the development of several vascular pathologies, particularly in atherosclerosis and in restenosis due to angioplasty. We have shown that butyrate, a powerful antiproliferative agent, a strong promoter of cell differentiation and an inducer of apoptosis inhibits VSMC proliferation at physiological concentrations with no cytotoxicity. In the present study, we have used cDNA array technology to unravel the molecular basis of the antiproliferative effect of butyrate on VSMCs. To assess the involvement of gene expression in butyrate-inhibited VSMC proliferation, proliferating VSMCs were exposed to 5 mmol/1 butyrate 1 through 5 days after plating. Expression profiles of 1,176 genes representing different functional classes in untreated control and butyrate treated VSMCs were compared. A total of 111 genes exhibiting moderate (2.0–5.0 fold∥ to strong (> 5.0 fold) differential expression were identified. Analysis of these genes indicates that butyrate treatment mainly alters the expression of four different functional classes of genes, which include: 43 genes implicated in cell growth and differentiation, 13 genes related to stress response, 11 genes associated with vascular function and 8 genes normally present in neuronal cells. Examination of differentially expressed cell growth and differentiation related genes indicate that butyrate-inhibited VSMC proliferation appears to involve down-regulation of genes that encode several positive regulators of cell growth and up-regulation of some negative regulators of growth or differentiation inducers. Some of the down-regulated genes include proliferating cell nuclear antigen (PCNA), retinoblastoma susceptibility related protein p130 (pRb), cell division control protein 2 homolog (cdc2), cyclin B1, cell division control protein 20 homolog (p55cdc), high mobility group (HMG) 1 and 2 and several others. Whereas the up-regulated genes include cyclin D1, p21WAF1, p14INK4B/p15INK5B, Clusterin, inhibitor of DNA binding 1 (ID1) and others. On the other hand, butyrate-responsive stress-related genes include some of the members of heat shock protein (HSP), glutathione-s-transferase (GST), and glutathione peroxidase (GSH-PXs) and cytochrome P450 (CYP) families. Additionally, several genes related to vascular and neuronal function are also responsive to butyrate treatment. Although involvement of genes that encode stress response, vascular and neuronal functional proteins in cell proliferation is not clear, cDNA expression array data appear to suggest that they may play a role in the regulation of cell proliferation. However, cDNA expression profiles indicate that butyrate-inhibited VSMC proliferation involves combined action of a proportionally large number of both positive and negative regulators of growth, which ultimately causes growth arrest of VSMCs. Furthermore, these butyrate-induced differential gene expression changes are not only consistent with the antiproliferative effect of butyrate but are also in agreement with the roles that these gene products play in cell proliferation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 362: 801-809, 1993

    Google Scholar 

  2. Schwartz SM, deBlois D, O'Brien ERM: The intima: Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995

    Google Scholar 

  3. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253: 1129-1132, 1991

    Google Scholar 

  4. Pastore CJ, Isner JM, Bacha PA, Kearney M, Pickering JG: Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo. Results of local versus systemic administration. Circ Res 77: 519-529, 1995

    Google Scholar 

  5. Simons M, Edelman ER, Rosenberg RD: Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 93: 2351-2356, 1994

    Google Scholar 

  6. The Multicenter European Research Trial with Cilazapril after angioplasty to prevent transluminal coronary obstruction and restenosis (Mercator) study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circ 86: 100-110, 1992

    Google Scholar 

  7. Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ: Inhibition of rat arterial cell proliferation by heparin. In vivo studies with anticoagulant and non-anticoagulant heparin. Circ Res 46: 625-634, 1980

    Google Scholar 

  8. Ranganna K, Joshi T, Yatsu FM: Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells. Atheroscler Thromb Vase Biol 15: 2273-2283, 1995

    Google Scholar 

  9. Ranganna K, Yatsu FM: Inhibition of platelet-derived growth factor-BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells. Arterioscler Thromb Vase Biol 17: 3420-3427, 1997

    Google Scholar 

  10. Ranganna K, Yatsu FM, Hayes BE, Milton SG, Jayakumar A: Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells. Mol Cell Biochem 205: 149-161, 2000

    Google Scholar 

  11. Cummings JH, Pomare EW, Branch WJ, Naylor CPE, MacFariane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227, 1987

    Google Scholar 

  12. Smith JG, German JB: Molecular and genetic effects of dietary derived butyric acid. Food Technol 49: 87-90, 1995

    Google Scholar 

  13. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H: Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterol 103: 51-56, 1992

    Google Scholar 

  14. Velazquez OC, Rombeau JL: Butyrate. Potential role in colon cancer prevention and treatment. Adv Exp Med Biol 427: 169-181, 1997

    Google Scholar 

  15. Kanauchi O, Iwanaga T, Mitsuyama K, Saiki T, Tsuruta O, Noguchi K, Toyonaga A: Pathophysiology of colonic mucosa, colitis and colon duplication. Butyrate from bacterial fermentation of germinated barley foodstuff preserves intestinal barrier function in experimental colitis in the rat model. J Gastroenterol Hepatol 14: 880-888, 1999

    Google Scholar 

  16. Wachtershauser A, Stein J: Rationale for the luminal provision of butyrate in intestinal disease. Eur J Nutr 39: 164-171, 2000

    Google Scholar 

  17. Prasad KN: Butyric acid: A small fatty acid with diverse biological functions. Life Sci 27: 1351-1358, 1980

    Google Scholar 

  18. Kruh J: Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biol 42: 65-82, 1982

    Google Scholar 

  19. Hague A, Butt AJ, Paraskeva C: The role of butyrate in human colonic epithelial cells: An energy source or inducer of differentiation and apoptosis? Proc Nutr Soc 55: 937-943, 1996

    Google Scholar 

  20. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway. Implications for the possible role of dietary fiber in the prevention of large-bowel cancer. Int J Cancer 55: 498-505, 1993

    Google Scholar 

  21. Hassig CA, Tong JK, Schreiber SL: Fiber-derived butyrate and the prevention of colon cancer. Chem Biol 4: 783-789, 1997

    Google Scholar 

  22. Avivi-Green C, Polak-Charcon S, Madar Z, Schwartz: Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: Correlation with colon cancer inhibition. Oncol Res 12: 83-95, 2000

    Google Scholar 

  23. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M: Modulation of colonic epithelial cell proliferation, histone acetylation and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52: 5906-5912, 1992

    Google Scholar 

  24. Csordas A: On the biological role of histone acetylation. Biochem J 265: 23-38, 1990

    Google Scholar 

  25. Kruh J, Tichonicky L, Defer N: Effect of butyrate on gene expression. In: H.J. Binder, J.H. Cummings, K. Soergel (eds). Short Chain Fatty Acids. Kluwer, Dordrecht, 1994, pp 135-147

    Google Scholar 

  26. Feng P, Ge L, Akyhani N, Liau G: Sodium butyrate is a potent modulator of smooth muscle cell proliferation and gene expression. Cell Prolif 29: 231-241, 1996

    Google Scholar 

  27. Papadopoulos V, Kapsis A, Li H, Amri H, Hardwick M, Culty M, Kasprzyk PG, Carlson M, Moreau J-P, Drieu K: Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. Anticancer Res 20: 2835-2848, 2000

    Google Scholar 

  28. Liang C-P, Tall AR: Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile add synthesis and transport with reversal by leptin treatment in Ob/ob mouse liver. J Biol Chem 276: 49066-49076, 2001

    Google Scholar 

  29. Gross C, Kelleher M, Iyer VR, Brown PO, Winge DR: Identification of the copper regulation in Saccharomyces cerevisiae by DNA microarrays. J Biol Chem 275: 32310-32316, 2000

    Google Scholar 

  30. Pietiainen V, Huttunen P, Hyypia T: Effects of echovirus 1 infection on cellular gene expression. Virol 276: 243-250, 2000

    Google Scholar 

  31. Eckmann L, Smith JR, Housley MP, Dwinell MB, Kagnoff MF: Analysis by high density cDNA arrays of altered gene expression in human intestinal epithelial cells in response to infection with the invasive enteric bacteria salmonella. J Biol Chem 275: 14084-14094, 2000

    Google Scholar 

  32. Hu D, Cao K, Peterson-Wakeman R, Wang R. Altered profile of gene expression in rat hearts induced by chronic nicotine consumption. Biochem Biophys Res Commun 297: 729-736, 2002

    Google Scholar 

  33. Mayanil CSK, George D, Freilich L, Miljan EJ, Mania-Farnell B, McLone DG, Bremer EG: Microarray analysis detects novel pax3 downstream target genes. J Biol Chem 276: 49299-49309, 2001

    Google Scholar 

  34. Kelman Z: PCNA: Structure, functions and interactions. Oncogene 14: 629-640, 1997

    Google Scholar 

  35. Hunter T, Pines J: Cyclins and cancer II: Cyclin D and cdk inhibitors come of age. Cell 79: 573-582, 1994

    Google Scholar 

  36. Peter M, Herskowitz I: Joining the complex: Cyclin-dependent kinase inhibitory proteins and cell cycle. Cell 79: 181-184, 1994

    Google Scholar 

  37. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, EI-Houscini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994

    Google Scholar 

  38. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H, Sakai T: Butyrate activates the WAF1/Cip1 Gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 272: 22199-22206, 1997

    Google Scholar 

  39. Harper, JW, Elledge SJ, Keyomarsi K, Dynlacht B, Bai L-H, Zhang P, Dobrowoski S, Bai C, Connell-Growley L, Swindell E, Fox MP, Wei N: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400, 1995

    Google Scholar 

  40. Luo Y, Hurwitz J, Massague J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375: 159-161, 1995

    Google Scholar 

  41. Bravo R: Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163: 287-293, 1986

    Google Scholar 

  42. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J 11: 961-971, 1992

    Google Scholar 

  43. Yan G-Z, Ziff EB: NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J Neurosci 15: 6200-6212, 1995

    Google Scholar 

  44. Weinstein J: Cell cycle-regulated expression, phosphorylation, and degradation of p55cdc. J Biol Chem 272: 28501-28511, 1997

    Google Scholar 

  45. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R: Genetic approaches in mice to understand rel/NF-kappaB and IkappaB function: Transgenics and knockouts. Oncogene 18: 6888-6895, 1999

    Google Scholar 

  46. Miyamoto S, Seufzer BJ, Shumway SD: Novel IβBa proteolytic pathway in WEHI231 immature B cells. Mol Cell Biol 18: 19-29, 1998

    Google Scholar 

  47. Yin L, Laevsky G, Giardina C: Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J Biol Chem 276: 44641-44646, 2001

    Google Scholar 

  48. Rihn BH, Mohr S, McDowell SA, Binet S, Loubinoux J, Galateau F, Keith G, Leikauf GD: Differential gene expression in mesothelioma. FEBS Lett 480: 95-100, 2000

    Google Scholar 

  49. Fukada T, Yoshida Y, Nishida K, Obtani T, Shirogane T, Hibi M, Hirano T: Signaling through Gp130: Toward a general scenario of cytokine action. Growth Factors 17: 81-91, 1999

    Google Scholar 

  50. Cervellera M, Raschella G, Santilli G, Tanno B, Ventura A, Mancini C, Sevignani C, Calabretta B, Sala A: Direct transactivation of the anti-apoptotic gene apolipoprotein J (Clusterin) by b-myb. J Biol Chem 275: 21055-21060, 2000

    Google Scholar 

  51. Imaizumi K, Morihara T, Mori Y, Katayamma T, Tsuda M, Furuyama T, Wanaka A, Takeda M, Tohyama M: The cell death-promoting gene DP5, which interacts with the bcl2 family, is induced during neuronal apoptosis following exposure to amyloid β protein. J Biol Chem 274: 7975-7981, 1999

    Google Scholar 

  52. Benjamin IJ, McMillan DR: Stress (heat shock) proteins. Molecular chaperones in cardiovascular biology and disease. Circ Res 83: 117-132, 1998

    Google Scholar 

  53. Liao D-F, Jin Z-G, Baas AS, Daum G, Gygi SP, Aebersold R, Berk BC: Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 275: 189-196, 2000

    Google Scholar 

  54. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, Webers LA, Gerthofferm WT: A role for p38MAPK/HSP27 pathway in smooth muscle cell migration. J Biol Chem 274: 24211-24219, 1999

    Google Scholar 

  55. Patton WF, Erdjument-Bromage H, Marks AR, Tempst P, Taubman MB: Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. J Biol Chem 270: 21404-21410, 1995

    Google Scholar 

  56. Madamanchi NR, Li S, Patterson C, Runge MS: Thrombin regulates vascular smooth muscle cell growth and heat shock proteins via the JAK-STAT pathway. J Biol Chem 276: 18915-18924, 2001

    Google Scholar 

  57. Hayes JD, Pulford DJ: The glutathione s-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995

    Google Scholar 

  58. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearson ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ: Mitogenic signaling mediated by Oxidants in ras-transformed fibroblasts. Science 275: 1649-1652, 1997

    Google Scholar 

  59. Wang J, Boja ES, Tan W, Teklen E, Fales HM, English S, Mieyal JJ, Chock PB: Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276: 47763-47766, 2001

    Google Scholar 

  60. Ursini F, Maiorino M, Brigelius-Flohe R, Aumann KD, Roveri A, Schomburg D, Flohe L: Diversity of glutathione peroxidases. Meth Enzymol 252: 38-53, 1995

    Google Scholar 

  61. Kang Y-J, Enger MD: Glutathione content and growth in A549 human lung carcinoma cells. Expt Cell Res 187: 177-179, 1990

    Google Scholar 

  62. Kirby ML, Waldo KL: Neural crest and cardiovascular patterning. Circ Res 77: 211-215, 1995

    Google Scholar 

  63. Jain MK, Layne MD, Watanabe M, Chin MT, Feinberg MW, Sibinga NES, Hsieh C-M, Yet S-F, Stemple DL, Lee M-E: In vitro system for differentiating pluripotent neural crest cells into smooth muscle cells. J Biol Chem 273: 5993-5996, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, 77004, USA

    Kasturi Ranganna, Zivar Yousefipour, Shirlette G. Milton & Barbara E. Hayes

  2. Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA

    Frank M. Yatsu

Authors
  1. Kasturi Ranganna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zivar Yousefipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frank M. Yatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shirlette G. Milton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Barbara E. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ranganna, K., Yousefipour, Z., Yatsu, F.M. et al. Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation. Mol Cell Biochem 254, 21–36 (2003). https://doi.org/10.1023/A:1027383710582

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1027383710582

Search

Navigation